InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,186.73
(
0.12%
)
US TECH 100
17,616.09
(
0.03%
)
Dow Jones
38,868.68
(
0.04%
)
Brent Oil
83.28
(
-0.24%
)
Bitcoin
63,232.19
(
0.10%
)
Post# of 2549
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DanSanTrades

Send PM Follow Ignore
Followers 0
Posts 29
Boards Moderated 0
Alias Born 05/07/2019

DanSanTrades

Re: None

Wednesday, 04/01/2020 3:38:42 AM

Wednesday, April 01, 2020 3:38:42 AM

Post# of 2549
NVAX ---- BIG Breakout just happened!!!!

Emergent BioSolutions Inc. has inked another deal with fellow Gaithersburg biotech Novavax Inc. — this time, for its seasonal flu vaccine.

The agreement means Emergent (NYSE: EBS) will develop and manufacture NanoFlu, the influenza vaccine which Novavax (NASDAQ: NVAX) successfully pushed through phase 3 clinical trials in a critical win announced March 24. It also comes just a few weeks after the two companies teamed up to get a COVID-19 vaccine to the clinic in the race against the pandemic.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up